Le Lézard
Classified in: Health, Science and technology
Subjects: Conference, Event, Trade Show, Advisory

Epic Bio to Participate in the 6th International Conference on Epigenetics and Bioengineering


Epic Bio, a biotechnology company developing therapies to modulate gene expression using compact, non-cutting dCas proteins, today announced its participation at the 6th International Conference on Epigenetics and Bioengineering, held in Houston, Texas, taking place October 27 ? 29, 2022.

ICEB 2022 Presentation Details:

Poster Presentation Title: GEMS: A Platform for Transcriptional and Epigenome Engineering in Human Disease
Session Name: Epigenetic Editing towards Clinic
Presenter: Daniel Hart, Ph.D., Head of Technology Development
Presentation Date/Time: October 29, 11:25 ? 11:50 a.m. CT

About Epic Bio

Epic Bio is a leading epigenetic engineering company, leveraging the power of CRISPR without cutting DNA. The company is using its proprietary Gene Expression Modulation System (GEMS) to develop therapies. Through the company's library of the most compact Cas DNA-binding proteins to work on human cells, the company is developing in vivo therapies with delivery via a single AAV vector. Epic Bio has an initial focus on Facioscapulohumeral Muscular Dystrophy (FSHD) and is conducting additional research to address Antitrypsin Deficiency (A1AD), Heterozygous Familial Hypocholesterolemia (HeFH), as well as other indications. The company is financially backed by Horizons Ventures and other leading investors. Visit www.epic-bio.com for more information or follow us on Twitter and LinkedIn.


These press releases may also interest you

at 12:05
HELIOS® by VirtualHealth Named Bronze Stevie® Award Winner in 2024 American Business Awards®
VirtualHealth is excited to share that its HELIOS platform was named the winner of a Bronze Stevie® Award in the Healthcare Technology Solution category in The 22nd Annual American Business Awards® today. More than 3,700 nominations were submitted...

at 12:02
Addressing stigma's impact on health: An event with Toronto Public Health
On May 1, 2024, Toronto Public Health (TPH) will host Diverse Dialogues: Stigma & Breaking Barriers. The event will bring together distinguished speakers to explore the challenging and thought-provoking topic about how negative labels and biases...

at 11:56
The Next Level Deep Plane Face and Neck Lift: A Revolutionary Procedure for Natural and Long-Lasting Results
As the demand for cosmetic procedures continues to rise, patients are seeking more advanced and effective options for achieving a youthful and rejuvenated appearance. In response to this, Dr. Ronald Demeo has introduced the Next Level Deep Plane Face...

at 11:50
Median Technologies Reports Full-year 2023 Financial Results and Provides First Quarter 2024 Financial Information
Regulatory News: Median Technologies (FR0011049824, ALMDT, PEA-PME scheme eligible, "Median" or the "Company") today reported its 2023 consolidated annual financial results, as of December 31, 2023, and provided financial information (unaudited)...

at 11:34
Report from Annual General Meeting of Vitrolife AB (publ)
At the Annual General Meeting of Vitrolife AB today, the following, amongst other things, was decided: Resolution in accordance with the Board's proposed dividend of SEK 1.00 per share for the financial year 2023. 29 April, 2024 was adopted as the...

at 11:25
TimelyCare Earns Recognition as One of the World's Best Digital Health Companies, Earns Five Top Workplace Awards
TimelyCare, higher education's most trusted virtual health and well-being provider, has earned recognition as one of the World's Best Digital Health Companies by Newsweek, and has been awarded five Top Workplaces Awards for culture excellence....

More news about Health...


News published on and distributed by: